<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3APyridoxamine%2F6%2Fen</id>
	<title>Translations:Pyridoxamine/6/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3APyridoxamine%2F6%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Pyridoxamine/6/en&amp;action=history"/>
	<updated>2026-08-25T10:26:16Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Pyridoxamine/6/en&amp;diff=134454&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Pyridoxamine/6/en&amp;diff=134454&amp;oldid=prev"/>
		<updated>2024-04-04T05:38:46Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Pyridoxamine also inhibits the formation of advanced lipoxidation endproducts during [[lipid peroxidation]] reactions by reaction with di[[carbonyl]] intermediates. In other preclinical research, pyridoxamine may be efficacious in treating [[diabetic neuropathy]] and [[retinopathy]] associated with diabetes and [[kidney stone]] disease. In one study, pyridoxamine was more effective at protecting from [[ionizing radiation]]-induced [[gastrointestinal]] [[epithelial]] [[apoptosis]] than [[amifostine]] (the only [[wikt:radioprotector|radioprotector]] currently [[Food and Drug Administration]] (FDA)-approved) due to pyridoxamine reactive oxygen species and reactive carbonyl species scavenging profile.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>